Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€60.50

€60.50

0.000%
-
0.000%
€64.22
 
18.09.24 / Tradegate WKN: A0LFMZ / Symbol: RDNT / Name: RadNet / Stock / Healthcare Providers & Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Radnet Inc. Stock

The Radnet Inc. price is unchanged compared to yesterday.
With 11 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 64 € there is a slightly positive potential of 5.79% for Radnet Inc. compared to the current price of 60.5 €.

Pros and Cons of Radnet Inc. in the next few years

Pros
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Radnet Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Radnet Inc. 0.000% 6.140% 3.419% 134.496% 86.728% - -
Addus Homecare Corp. 0.860% 4.464% 0.000% 51.948% 39.286% 63.636% 66.028%
Surgery Partners Inc 2.860% 4.348% 9.091% -1.370% 0.000% -26.154% 319.031%
Capital Senior Living Corp. -0.870% -0.870% -20.833% 178.049% 163.584% -8.800% -60.282%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-15

RadNet, a prominent player in the Healthcare Providers & Services industry with the US trading symbol RDNT, showcases a distinctly mixed financial performance. While the company has exhibited steady growth in its total assets and revenue, some critical ratios and financial indicators present a more nuanced picture. To better understand the intricacies of RadNet's financials, let's examine the pros and cons of its various financial aspects.

Revenue growth: Over the past three years, RadNet's total revenue has risen consistently. From a total revenue of $1.07 billion in 2020, the company experienced growth, reaching $1.31 billion in 2021 and further to $1.43 billion in 2022. This revenue growth indicates a positive market presence and expanded operations.

Increased total assets: A similar trend is observed in the company's total assets, with figures growing from $1.79 billion in 2020 to $2.06 billion in 2021 and even further to $2.43 billion in 2022. This growth can imply that the company is making considerable investments to enhance its operational capabilities.

Comments

Prediction Buy
Perf. (%) 2.54%
Target price 71.013
Change
Ends at 06.09.25

RadNet, Inc. (NASDAQ: RDNT) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $79.00 price target on the stock, up previously from $57.00.
Ratings data for RDNT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 4.31%
Target price 64.218
Change
Ends at 16.07.25

RadNet, Inc. (NASDAQ: RDNT) had its price target raised by analysts at Truist Financial Co. from $63.00 to $70.00. They now have a "buy" rating on the stock.
Ratings data for RDNT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 9.01%
Target price 68.925
Change
Ends at 11.07.25

RadNet, Inc. (NASDAQ: RDNT) had its price target raised by analysts at Jefferies Financial Group Inc. from $61.00 to $75.00. They now have a "buy" rating on the stock.
Ratings data for RDNT provided by MarketBeat
Show more